Why the study?
Whether occupational therapy improves health-related quality of life, activities of daily living, fatigue, occupational performance, rehospitalization, and mortality in patients with cardiovascular disease remained unclear.
Does occupational therapy improve HRQOL, ADLs, fatigue, occupational performance, rehospitalization, and mortality in patients with cardiovascular disease?
Does occupational therapy improve HRQOL, ADLs, fatigue, occupational performance, rehospitalization, and mortality in patients with cardiovascular disease?
Current evidence is insufficient to demonstrate a clear benefit of occupational therapy on quality of life or daily activities in patients with cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Evidence too limited to support occupational therapy for HRQOL or ADLs in CVD; leaves open whether larger trials would show benefit.
Background: The prevalence of cardiovascular diseases (CVD) is high worldwide. Occupational therapy (OT) allows individuals to participate in activities of daily living (ADLs) and improves their quality of life. However, whether OT improves health-related quality of life (HRQOL), ADLs, fatigue, occupational performance, rehospitalization, and mortality in patients with CVD remains unclear. This study aimed to determine whether OT improves HRQOL, ADLs, fatigue, occupational performance, rehospitalization, and mortality in patients with CVD using a systematic review and meta-analysis. Methods and Results: A literature search of 3 databases in October 2024 yielded 4 RCTs on OT in CVD patients. Two trials (n=208) assessed HRQOL, while 2 others (n=220) examined ADLs. One trial (n=23) evaluated fatigue and occupational performance, and another (n=93) assessed rehospitalization and mortality. Due to insufficient data on HRQOL and ADL improvement in 1 trial, a meta-analysis was not feasible. Similarly, a meta-analysis of fatigue, occupational performance, rehospitalization, and mortality could not be performed due to the limited number of studies. Conclusions: The results showed no clear evidence that OT improves HRQOL or ADLs in patients with CVD.
No takes yet. Share an insight, caveat, or question.
Takeda et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: